Gary R Morrow
Overview
Explore the profile of Gary R Morrow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
5413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chua Jr A, Delmerico J, Sheng H, Huang X, Liang E, Yan L, et al.
JCO Oncol Pract
. 2024 Aug;
21(3):408-417.
PMID: 39173090
Purpose: Minoritized racial/ethnic groups are historically under-represented in cancer clinical trials, which may be exacerbated in recent trials on immune checkpoint inhibitors (ICIs). We examined the representation and reporting of...
2.
Gewandter J, Culakova E, Davis J, Gada U, Guido J, Bearden J, et al.
J Pain
. 2023 Nov;
25(5):104431.
PMID: 37993030
Chemotherapy-induced peripheral neuropathy (CIPN) affects approximately 30 to 60% of people who receive neurotoxic chemotherapy. CIPN is associated with impaired quality of life and function and has few effective treatments....
3.
Yao S, Ambrosone C, Osarogiagbon R, Morrow G, Kamen C
Trends Cancer
. 2022 Oct;
9(1):6-8.
PMID: 36280546
The approval and wide uptake of immune checkpoint inhibitors (ICIs) in oncology practice raise the concerns of possibly worsened racial disparities in cancer treatment due to biological and psychosocial reasons....
4.
Devlin E, Whitford H, Peoples A, Morrow G, Katragadda S, Giguere J, et al.
Eur J Cancer Care (Engl)
. 2021 Jul;
30(6):e13488.
PMID: 34323340
Objective: Chemotherapy-induced nausea is challenging to predict and treat. Research indicates that pretreatment psychological variables including patients' perceptions of their susceptibility to nausea, expectancies of treatment-related nausea and nausea history...
5.
Janelsins M, Mohamed M, Peppone L, Magnuson A, Belcher E, Melnik M, et al.
J Natl Cancer Inst
. 2021 Jul;
114(1):47-59.
PMID: 34255086
Background: Cancer-related cognitive decline (CRCD) is an important clinical problem, but limited research exists on assessment of cognitive function in patients with lymphoma. Methods: The overall objective of this nationwide,...
6.
Peoples A, Pigeon W, Li D, Garland S, Perlis M, Inglis J, et al.
J Pain Symptom Manage
. 2020 Aug;
61(2):254-261.
PMID: 32768555
Context: Pain can be a debilitating side effect of radiation therapy (RT). Data from the general population have shown that sleep disturbance can influence pain incidence and severity; however, less...
7.
Wolf J, Gewandter J, Bautista J, Heckler C, Strasser J, Dyk P, et al.
Support Care Cancer
. 2019 Nov;
28(7):3303-3311.
PMID: 31758326
Purpose: Although topical agents are often provided during radiation therapy, there is limited consensus and evidence for their use prophylactically to prevent or reduce radiation dermatitis. Methods: This was a...
8.
Mohile S, Epstein R, Hurria A, Heckler C, Canin B, Culakova E, et al.
JAMA Oncol
. 2019 Nov;
6(2):196-204.
PMID: 31697365
Importance: Older patients with cancer and their caregivers worry about the effects of cancer treatment on aging-related domains (eg, function and cognition). Quality conversations with oncologists about aging-related concerns could...
9.
Xu Z, Becerra A, Justiniano C, Aquina C, Fleming F, Boscoe F, et al.
J Surg Res
. 2019 Sep;
246:34-41.
PMID: 31561176
Background: We examined factors associated with postoperative complications, 1-year overall and cancer-specific survival after epithelial ovarian cancer (EOC) diagnosis. Methods: Patients who underwent surgery for EOC between 2004 and 2013...
10.
Kleckner A, Kleckner I, Kamen C, Tejani M, Janelsins M, Morrow G, et al.
Ther Adv Med Oncol
. 2019 Aug;
11:1758835919866362.
PMID: 31413731
Cannabis has the potential to modulate some of the most common and debilitating symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and pain. However, the...